This Plain Language Summary of Publication article (PLSP) from Future Rare Diseases evaluated the safety and effectiveness of fosdenopterin/recombinant cyclic pyranopterin monophosphate (rcPMP) in treating molybdenum cofactor deficiency (MoCD) Type A, a rare inherited disease.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Increased Survival in Patients With Molybdenum Cofactor Deficiency Type A Treated With Cyclic Pyranopterin Monophosphate’ and was published in the Journal of Inherited Metabolic Disease.

Visit Wiley using the link to read the original article.